{"id":"W4220707089","doi":"10.1016/j.jaip.2022.02.026","title":"Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases","year":2022,"lang":"en","type":"article","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Sanofi Genzyme; Genentech; LEO Pharma; GlaxoSmithKline; Merck; MedImmune; Vanda Pharmaceuticals; Amgen; Boehringer Ingelheim; Regeneron Pharmaceuticals; Novartis; Galderma; AstraZeneca; Pfizer; DalCor Pharmaceuticals; Sanofi","keywords":"Medicine; Dupilumab; Eczema Area and Severity Index; Dermatology Life Quality Index; Atopic dermatitis; Asthma; Placebo; Internal medicine; Quality of life (healthcare); Severity of illness; Bronchodilator; Gastroenterology; Dermatology; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009302367,0.0004593061,0.0007757269,0.0003086175,0.0004237575,0.0009380133,0.0002072523,0.0006147036,0.001791141],"category_scores_gemma":[0.001357845,0.0002071135,0.0006067355,0.0002990678,0.0002491788,0.0004233719,0.0003355939,0.001358857,0.0005282882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005566399,"about_ca_system_score_gemma":0.0005110548,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009424431,"about_ca_topic_score_gemma":0.001722994,"domain_scores_codex":[0.9992228,0.0001459487,0.00007685761,0.0001423293,0.0001673924,0.0002447119],"domain_scores_gemma":[0.9990563,0.0002768299,0.0001606024,0.00009548437,0.0001603763,0.0002502703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02420971,0.002117512,0.2069334,0.001004879,0.0005389258,0.003039613,0.0004436783,0.001105197,0.4922765,0.0003523841,0.005122845,0.2628553],"study_design_scores_gemma":[0.0007035105,0.02399623,0.847077,0.0000934947,0.0004324718,0.00798948,0.0004156557,0.001382386,0.1049181,0.0002584139,0.0126544,0.00007890686],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878201,0.004148602,0.001382002,0.000329371,0.0001714928,0.0001947079,0.0007805324,0.0001887429,0.004984519],"genre_scores_gemma":[0.9965276,0.0005209194,0.001008434,0.0004759288,0.0000462255,0.00008179562,0.0005248334,0.00002492652,0.000789243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001791141,"threshold_uncertainty_score":0.005991995,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03001278810058661,"score_gpt":0.373190354969632,"score_spread":0.3431775668690454,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}